Change in metabolic parameters and reproductive hormones from baseline to 6-month hormone therapy

Adequate evidence showed hormone therapy (HT) reduces the risk of new-onset diabetes in midlife women by decreasing fasting glucose and insulin. However, the improvement of these diabetic biomarkers varied with each individual in clinical observations. The objective of our study was to investigate p...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Tongyun, Wang, Xueqing, Huang, Yizhou, Song, Yang, Ma, Linjuan, Ying, Qian, Chatooah, Namratta Devi, Lan, Yibin, Chen, Peiqiong, Xu, Wenxian, Chu, Ketan, Ruan, Fei, Zhou, Jianhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735779/
https://www.ncbi.nlm.nih.gov/pubmed/35029882
http://dx.doi.org/10.1097/MD.0000000000028361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735779/
https://www.ncbi.nlm.nih.gov/pubmed/35029882
http://dx.doi.org/10.1097/MD.0000000000028361

Ejemplares similares